These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 8099562

  • 1. [A study on the pharmacological action of phencyclidine].
    Ohmori T.
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):205-13. PubMed ID: 8099562
    [Abstract] [Full Text] [Related]

  • 2. Effect of phencyclidine on spontaneous and N-methyl-D-aspartate (NMDA)-induced efflux of dopamine from superfused slices of rat striatum.
    Ohmori T, Koyama T, Nakamura F, Wang P, Yamashita I.
    Neuropharmacology; 1992 May; 31(5):461-7. PubMed ID: 1528397
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
    Umino A, Takahashi K, Nishikawa T.
    Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
    Sershen H, Balla A, Aspromonte JM, Xie S, Cooper TB, Javitt DC.
    Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
    [Abstract] [Full Text] [Related]

  • 6. Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
    Jones SM, Snell LD, Johnson KM.
    J Pharmacol Exp Ther; 1987 Feb; 240(2):492-7. PubMed ID: 2879908
    [Abstract] [Full Text] [Related]

  • 7. Presynaptic dopaminergic activity of phencyclidine in rat caudate.
    Johnson SW, Haroldsen PE, Hoffer BJ, Freedman R.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):321-32. PubMed ID: 6707946
    [Abstract] [Full Text] [Related]

  • 8. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
    Snell LD, Mueller ZL, Gannon RL, Silverman PB, Johnson KM.
    J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
    [Abstract] [Full Text] [Related]

  • 9. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
    Snell LD, Johnson KM.
    J Pharmacol Exp Ther; 1985 Oct; 235(1):50-7. PubMed ID: 2864436
    [Abstract] [Full Text] [Related]

  • 10. Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices.
    Vickroy TW, Johnson KM.
    J Pharmacol Exp Ther; 1982 Dec; 223(3):669-74. PubMed ID: 6128403
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y, Mitsushio H, Takahashi K, Nishikawa T.
    Synapse; 2000 Mar 15; 35(4):292-9. PubMed ID: 10657039
    [Abstract] [Full Text] [Related]

  • 12. The role of antagonism of NMDA receptor-mediated neurotransmission and inhibition of the dopamine reuptake in the neuroendocrine effects of phencyclidine.
    Pechnick RN, Bresee CJ, Poland RE.
    Life Sci; 2006 Mar 20; 78(17):2006-11. PubMed ID: 16288927
    [Abstract] [Full Text] [Related]

  • 13. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D, Zhang J, Engel JA, Svensson L.
    Behav Brain Res; 2005 Apr 15; 159(1):95-103. PubMed ID: 15795002
    [Abstract] [Full Text] [Related]

  • 14. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
    Arvanov VL, Wang RY.
    J Pharmacol Exp Ther; 1999 May 15; 289(2):1000-6. PubMed ID: 10215680
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
    Seillier A, Giuffrida A.
    Behav Brain Res; 2009 Dec 07; 204(2):410-5. PubMed ID: 19716985
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
    Nicholson KL, Jones HE, Balster RL.
    Behav Pharmacol; 1998 May 07; 9(3):231-43. PubMed ID: 9832937
    [Abstract] [Full Text] [Related]

  • 17. Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex.
    Jentsch JD, Wise A, Katz Z, Roth RH.
    Synapse; 1998 Jan 07; 28(1):21-6. PubMed ID: 9414014
    [Abstract] [Full Text] [Related]

  • 18. The effect of phencyclidine and DL-2-amino-5-phosphonovaleric acid on N-methyl-D-aspartic acid induced changes in extracellular concentration of dopamine and DOPAC in the rat neostriatum.
    Marek P, Chapman CD, Howard S.
    Neuropharmacology; 1992 Feb 07; 31(2):123-7. PubMed ID: 1348111
    [Abstract] [Full Text] [Related]

  • 19. Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine.
    Shi WX, Zhang XX.
    J Pharmacol Exp Ther; 2003 May 07; 305(2):680-7. PubMed ID: 12606677
    [Abstract] [Full Text] [Related]

  • 20. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.
    Bakshi VP, Geyer MA.
    J Pharmacol Exp Ther; 1997 Nov 07; 283(2):666-74. PubMed ID: 9353384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.